Jan‐Show Chu
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Oncology top 5%
- Cancer-related Molecular Pathways
- Viral-associated cancers and disorders
Papers in
-
- Angiogenesis and VEGF in Cancer 7
- Wnt/β-catenin signaling in development and cancer 4
- Oncology 23
- Cancer-related Molecular Pathways 10
- Co-authors
- Po‐Lin Lai (2 shared papers)Yung‐Ming Jeng (2 shared papers)Tsui‐Lien Mao (2 shared papers)Hey‐Chi Hsu (1 shared paper)Shian‐Yang Peng (1 shared paper)King‐Jen Chang (6 shared papers)Yuan‐Soon Ho (3 shared papers)Chih‐Hsiung Wu (5 shared papers)
- Journals
- Cancer Letters (4 papers)Medical Education (2 papers)Diagnostic Pathology (2 papers)The Journal of Urology (2 papers)BMC Medical Education (2 papers)
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Jan‐Show Chu
72 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 132
- Cancer Research 369
- Oncology 503
- Hepatology 135
- Molecular Biology 991
- Pathology and Forensic Medicine 251
Countries citing papers authored by Jan‐Show Chu
This map shows the geographic impact of Jan‐Show Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan‐Show Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan‐Show Chu more than expected).
Fields of papers citing papers by Jan‐Show Chu
This network shows the impact of papers produced by Jan‐Show Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan‐Show Chu. The network helps show where Jan‐Show Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan‐Show Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 241 | |
| 2 | 2010 | 150 | |
| 3 | 2009 | 105 | |
| 4 | 2001 | 95 | |
| 5 | 1999 | 85 | |
| 6 | 2010 | 82 | |
| 7 | 2003 | 67 | |
| 8 | 1998 | 66 | |
| 9 | Intracranial epidermoid cyst with hemorrhage: MR imaging findings. | 2006 | 61 |
| 10 | 2009 | 60 | |
| 11 | 2014 | 54 | |
| 12 | 1995 | 50 | |
| 13 | 1995 | 49 | |
| 14 | 2006 | 46 | |
| 15 | 2014 | 46 | |
| 16 | 2006 | 43 | |
| 17 | 2002 | 35 | |
| 18 | 1995 | 34 | |
| 19 | 2004 | 32 | |
| 20 | 2001 | 30 |
About Jan‐Show Chu
Jan‐Show Chu is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Surgery and Cancer Research, having authored 74 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (10 papers), Angiogenesis and VEGF in Cancer (7 papers), Breast Lesions and Carcinomas (6 papers), Cancer and Skin Lesions (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Endometrial and Cervical Cancer Treatments (4 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and Arsenic contamination and mitigation (3 papers). The work is most often cited by research in Cancer Research (369 citations), Oncology (503 citations), Hepatology (135 citations), Molecular Biology (991 citations) and Pathology and Forensic Medicine (251 citations). Jan‐Show Chu has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Po‐Lin Lai, Yung‐Ming Jeng, Tsui‐Lien Mao, Hey‐Chi Hsu, Shian‐Yang Peng, King‐Jen Chang, Yuan‐Soon Ho, Chih‐Hsiung Wu, Shih‐Hsin Tu and Chia‐Hwa Lee. Their work appears in journals such as Cancer Letters, Medical Education, Diagnostic Pathology, The Journal of Urology and BMC Medical Education.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.